About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITING

URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS

FACTORS ASSOCIATED WITH URINARY INCONTINENCE AND EVALUATION OF PELVIC FLOOR MUSCLE ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS: CROSS-SECTIONAL STUDY

NCT07489794•Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Multiple SclerosisUrinary Incontinence (UI)

Locations

1

Turkey (Türkiye)

Locations (1)

Istanbul, Prof. Dr. Cemil Taşçıoğlu City Hospital, Turkey

Istanbul, Turkey (Türkiye)

Key Dates

Start Date

March 9, 2026

Primary Completion Date

September 20, 2026

Completion Date

October 30, 2026

Last Updated

March 24, 2026

Related Studies

RECRUITINGPhase 3

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

NCT07325292

Multiple Sclerosis

Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis

NCT05748015

Multiple Sclerosis

Reducing Disparities in Urinary Control Symptoms for Minority Women

NCT06798311

Urinary Incontinence (UI)Lower Urinary Tract Symptoms (LUTS)+1 more

Sonification Techniques for Gait Training

NCT04876339

Parkinson DiseaseStroke+1 more

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

NCT05344469

Relapsing Multiple Sclerosis

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504

Secondary Progressive Multiple Sclerosis (SPMS)

View all related studies

Contacts

Büşra Aydın Erkılıç, MSc

CONTACT

905062214052 bsrr.aydinn@gmail.com

Sponsors

Lead Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2026Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions